Hyaluronidase (nonspecified Subtype): Potential Drug Targets (P11329)

Target Name: Hyaluronidase

NCBI ID: P11329

Hyaluronidase

Other Name(s): Hyaluronoglucosaminidase | Hyal

Hyaluronidase (nonspecified Subtype): Potential Drug Targets

Hyaluronidase (nonspecified subtype), also known as hyaluronoglucosaminidase, is a enzyme that is involved in the degradation of hyaluronic acid, a component of connective tissue that helps to keep tissue hydrated and flexible. Hyaluronic acid is naturally produced by the body and is also obtained from dietary sources such as fruits and vegetables. The role of hyaluronic acid in maintaining tissue hydration is crucial for maintaining the health and function of various tissues and organs.

Hyaluronidase (nonspecified subtype) is a protein that is expressed in a wide range of tissues throughout the body, including the liver, spleen, pancreas, and various muscle and nerve fibers. It is a member of the glycosaminidase family 2 (GAS) and is responsible for the breakdown of hyaluronic acid. This process is essential for maintaining the proper structure and function of hyaluronic acid and is critical for maintaining tissue hydration.

Hyaluronidase (nonspecified subtype) is a protein that is expressed in a wide range of tissues throughout the body, including the liver, spleen, pancreas, and various muscle and nerve fibers.

Hyaluronic acid is a naturally occurring component of connective tissue that helps to keep tissue hydrated and flexible. It is produced by the body and is also obtained from dietary sources such as fruits and vegetables. The role of hyaluronic acid in maintaining tissue hydration is crucial for maintaining the health and function of various tissues and organs.

Hyaluronidase (nonspecified subtype) is a member of the glycosaminidase family 2 (GAS) and is responsible for the breakdown of hyaluronic acid. This process is essential for maintaining the proper structure and function of hyaluronic acid and is critical for maintaining tissue hydration.

Hyaluronidase (nonspecified subtype) is a potentially drug-able target for new therapies. Studies have shown that inhibiting hyaluronidase (nonspecified subtype) has potential therapeutic benefits for a variety of conditions, including arthritis, autoimmune diseases, and certain types of cancer. In addition, compounds that are similar to hyaluronidase (nonspecified subtype) have been shown to be effective in treating certain types of cancer.

One of the main challenges in studying hyaluronidase (nonspecified subtype) is its complex structure. The protein is composed of multiple domains, including an N-terminal alpha-helicase domain, a catalytic domain, and a C-terminal N-acetylglucosamide (NAG) domain. The N-terminal domain is responsible for the formation of the hyaluronic acid degradation pathway, while the catalytic domain is responsible for the catalytic activity of the enzyme. The C-terminal domain is thought to play a role in the regulation of the enzyme's activity.

While further research is needed, studies have shown that inhibiting hyaluronidase (nonspecified subtype) can have significant therapeutic benefits for a variety of conditions. For example, studies have shown that inhibiting the activity of hyaluronidase (nonspecified subtype) can reduce inflammation and pain in individuals with rheumatoid arthritis. In addition, compounds that are similar to hyaluronidase (nonspecified subtype) have been shown to be effective in treating certain types of cancer, such as breast cancer.

In conclusion, hyaluronidase (nonspecified subtype) is a protein that is involved in the degradation of hyaluronic acid, a component of connective tissue that helps to keep tissue hydrated and flexible. Studies have shown that inhibiting hyaluronidase (nonspecified subtype) has potential therapeutic benefits for a variety of conditions, including arthritis, autoimmune diseases, and certain types of cancer. Further research is needed to fully understand the potential of hyaluronidase (nonspecified subtype) as a drug

Protein Name: Hyaluronidase (nonspecified Subtype)

The "Hyaluronidase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Hyaluronidase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets